Has Walter Whitley, MD received payments from drug or device companies?

Yes. Drug and device makers reported $546,380 in general payments to Walter Whitley, MD across 1,085 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Walter Whitley, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Walter Whitley, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Walter Whitley, MD

Optometrist · Norfolk, VANPI 1013976711

Payments from drug & device makers

$546,380in general payments, 2019–2025

Across 1,085 payments — averaging $503.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bausch & Lomb Americas Inc.$89K
Alcon$72K
Sun Pharmaceutical Industries Inc.$70K
Tarsus Pharmaceuticals, Inc.$50K
AbbVie$48K
Oyster Point Pharma, Inc.$34K
plus $183K from 38 others

$7,418in research payments, 2019–2025

Across 2 payments — averaging $3709.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$4K
Oyster Point Pharma, Inc.$3K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bausch & Lomb Americas Inc.	135	$89,281
Alcon	120	$72,175
Sun Pharmaceutical Industries Inc.	138	$69,764
Tarsus Pharmaceuticals, Inc.	86	$49,672
AbbVie(2 entities)	135	$48,045
Oyster Point Pharma, Inc.	53	$34,426
Dompe US, Inc.	48	$28,350
Novartis	35	$26,061
Sight Sciences, Inc.	44	$24,216
Kala Pharmaceuticals, Inc.	33	$20,592
Shire North American Group Inc	29	$14,080
Harrow Eye, LLC	33	$10,714
Bausch & Lomb, A Division Of Bausch Health US, LLC	12	$7,171
Eyevance Pharmaceuticals LLC	27	$7,102
Aerie Pharmaceuticals, Inc.	13	$6,770
Johnson & Johnson Surgical Vision, Inc.	6	$5,763
Alcon Research LLC	4	$5,750
Apellis Pharmaceuticals, Inc.	7	$4,939
Tearlab Corp	10	$3,330
Biotissue Holdings Inc.	26	$3,228
Amgen(2 entities)	13	$2,664
Thea Pharma Inc.	9	$2,348
Vertical Pharmaceuticals, LLC	1	$2,150
Quidel Corporation	6	$1,329
Glaukos Corporation	5	$1,249
Beaver-visitec International, Inc.	1	$1,000
Carl Zeiss Meditec, Inc.	7	$846
Mallinckrodt Hospital Products Inc.	27	$756
Lumenis BE Inc	1	$700
Coopervision Inc.	1	$664
Notal Vision, Inc.	1	$307
NEW World Medical,inc.	4	$292
Topcon Healthcare, Inc.	1	$217
Carl Zeiss Meditec USA, Inc.	2	$165
Rayner Intraocular Lenses Limited	2	$66
Johnson & Johnson Vision Care, Inc.	2	$39
Immunogen, Inc.	1	$33
Regeneron Healthcare Solutions, Inc.	1	$24
LKC Technologies, Inc.	1	$20
Mallinckrodt Enterprises LLC	1	$19
Alimera Sciences, Inc.	1	$17
Rxsight Inc	1	$17
Maculogix, Inc.	1	$17
Lombart Brothers, Inc.	1	$11

How this compares

$546,380 in reported general payments places this provider in the 95th percentile of 1,230 optometrist providers in Virginia.

See all optometrist providers in Virginia →

Medicare billing

Part B allowed, 2024

$242,590

Medicare patients

1,017

Services billed

3,162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other optometrist in Norfolk

Katherine RachonNorfolk$15K
Ranjani PandaNorfolk$9K
Timothy PolingRoanoke$1.4M
Sushil JainFairfax$201K
Stacy MartinsonVirginia Beach$110K
Jacqueline TheisRichmond$80K
Joseph AllenRichmond$75K
Keith SmithsonReston$74K
Michael SwattsChesapeake$59K
Kurt DevitoVirginia Beach$54K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →